BSX INVESTOR ALERT: Boston Scientific Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit – RGRD Law

SAN DIEGO, March 22, 2026 (GLOBE NEWSWIRE) -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Boston Scientific Corporation (NYSE:BSX) common stock between July 23, 2025 and February 3, 2026, both dates inclusive (the "Class Period"), have until May 4, 2026 to seek appointment as lead plaintiff of the Boston Scientific class action lawsuit. Captioned Troike v. Boston Scientific Corporation, No. 26-cv-40075 (D. Mass.), the Boston Scientific class action lawsuit charges Boston Scientific as well as certain of Boston Scientific's top executives with violations of the Securities Exchange Act of 1934.

If you suffered substantial losses and wish to serve as lead plaintiff of the Boston Scientific class action lawsuit, please provide your information here:

https://www.rgrdlaw.com/cases-boston-scientific-corporation-class-action-lawsuit-bsx.html

You can also contact attorney J.C. Sanchez of Robbins Geller by calling 800/449-4900 or via e-mail at [email protected] .

CASE ALLEGATIONS: Boston Scientific develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide.

The Boston Scientific class action lawsuit alleges that defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (i) defendants created the false impression that they possessed reliable information pertaining to Boston Scientific's projected revenue outlook and anticipated growth while also minimizing risk from seasonality and macroeconomic fluctuations; and (ii) Boston Scientific's ambition of ...

Full story available on Benzinga.com